Sigma Planning Corp’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,483
| Closed | -$123K | – | 1353 |
|
|
2022
Q4 | $123K | Hold |
13,483
| – | – | ﹤0.01% | 1177 |
|
|
2022
Q3 | $109K | Buy |
+13,483
| New | +$109K | ﹤0.01% | 1183 |
|
|
2021
Q4 | – | Sell |
-10,043
| Closed | -$98K | – | 1444 |
|
|
2021
Q3 | $98K | Buy |
+10,043
| New | +$98K | ﹤0.01% | 1303 |
|
|
2018
Q4 | – | Sell |
-9,896
| Closed | -$213K | – | 946 |
|
|
2018
Q3 | $213K | Sell |
9,896
-1,000
| -9% | -$21.5K | 0.01% | 838 |
|
|
2018
Q2 | $265K | Sell |
10,896
-2,446
| -18% | -$59.5K | 0.02% | 701 |
|
|
2018
Q1 | $228K | Buy |
13,342
+2,037
| +18% | +$34.8K | 0.02% | 723 |
|
|
2017
Q4 | $214K | Buy |
+11,305
| New | +$214K | 0.02% | 748 |
|
|
2017
Q1 | – | Sell |
-23,255
| Closed | -$843K | – | 811 |
|
|
2016
Q4 | $843K | Buy |
23,255
+12,551
| +117% | +$455K | 0.09% | 237 |
|
|
2016
Q3 | $493K | Buy |
10,704
+484
| +5% | +$22.3K | 0.06% | 346 |
|
|
2016
Q2 | $513K | Buy |
+10,220
| New | +$513K | 0.07% | 317 |
|
|
2015
Q2 | – | Sell |
-3,347
| Closed | -$209K | – | 767 |
|
|
2015
Q1 | $209K | Sell |
3,347
-172
| -5% | -$10.7K | 0.03% | 658 |
|
|
2014
Q4 | $202K | Buy |
+3,519
| New | +$202K | 0.03% | 632 |
|